浙江健新原力制藥有限公司落戶于杭州臨空經(jīng)濟(jì)示范區(qū)，是杭州灣生物科技谷核心企業(yè)，總投資20億元，創(chuàng)始人余國良博士和李玉玲博士均為CBA前任會(huì)長。公司一期占地面積約125畝，總建筑面積約18萬平方米，建設(shè)包括生物醫(yī)藥工藝開發(fā)實(shí)驗(yàn)室，小試和中試基地，若干條商業(yè)化單克隆抗體生產(chǎn)線，細(xì)胞治療和基因治療的開發(fā)產(chǎn)能。健新原力的目標(biāo)是建立符合全球標(biāo)準(zhǔn)的生物藥制造能力，帶動(dòng)中國和全球主要市場間生物創(chuàng)新藥物的研發(fā)和商業(yè)轉(zhuǎn)化趨勢。 2018年度蕭山“5213”項(xiàng)目重點(diǎn)企業(yè) 2018年度蕭山金鳳凰企業(yè)2018年度空港經(jīng)濟(jì)區(qū)重點(diǎn)企業(yè) 2018年度全省僑界“十佳”回國投資創(chuàng)業(yè)企業(yè) 2019年度蕭山金鳳凰企業(yè) 2019年杭州市“大好高”項(xiàng)目 2019年新原力生物技術(shù)全球高峰論壇成功舉辦 2019年余國良董事長榮獲全球浙商金獎(jiǎng) Why Join Innoforce: We not only offer a dream location and competitive compensation package, but more importantly also provide career development and growth opportunity in an outstanding team environment for a noble cause. Opportunity#1: Join a stellar team to create a benchmark facility for Monoclonal antibodies, Gene and Cell Therapies, Cell Culture Medium, Fill Finish and others. Opportunity #2: If you are an experienced professional, you’ll have the opportunity to advance your career and take on increasing responsibilities to grow and lead the Innoforce development and manufacturing teams from Design to Commercialization. Opportunity #3: If you are a fresh/recent grad, we warmly welcome you as well, as we’ll provide you outstanding learning opportunity while you work with world class expertise and leaders as we build the company from ground up. When the company is in full swing GMP operations in a couple years, you will become supervisors and future leaders.